Bryan Hubbard & Angela Skudin: Hope for Veterans & First Responders as Texas Says YES to Ibogaine

Learn why Texas is leading the charge to make this non-addictive compound a legal treatment for veterans, first responders, and beyond by passing Texas House Bill 3717 with historic bipartisan support!

Discover the transformative power of Ibogaine, a plant-based medicine poised to revolutionize addiction recovery and mental health treatment. Bryan Hubbard, Executive Director of the American Ibogaine Initiative, and Angela Skudin from the Casey Skudin 343 Fund share their inspiring journeys, revealing how Ibogaine heals opioid addiction, PTSD, and chronic conditions. Learn why Texas is leading the charge to make this non-addictive compound a legal treatment for veterans, first responders, and beyond by passing Texas House Bill 3717 with historic bipartisan support!

Support the cause at www.343fund.org and share this video to spread the word!

#Ibogaine #OpioidCrisis #PlantMedicine #AddictionRecovery #mentalhealth

0:07 - Opening Prayer and Introduction
The video begins with a prayer led by Bryan Hubbard, emphasizing the mission to elevate the human soul and setting a spiritual tone for the discussion.

0:44 - Introduction of Guests and Show Context
Bryan Hubbard and Angela Skudin are introduced, along with the Casey Skudin 343 Fund, establishing the focus on the Ibogaine initiative.

1:10 - Overview of the Texas Ibogaine Initiative
The conversation shifts to the Texas Ibogaine Initiative, highlighting its importance and Bryan’s leadership in bringing it from Kentucky to Texas.

1:40 - Bryan’s Background and the Opioid Crisis
Bryan discusses his legal career and role in Kentucky’s social security disability system, linking it to the opioid epidemic’s origins with OxyContin in 1996.

2:14 - Scale of the Opioid Epidemic
Bryan explains Kentucky’s high disability rates and the explosive growth of opioid prescriptions, framing the epidemic’s impact.

3:00 - Kentucky’s Opioid Commission and Settlements
Bryan details his leadership of Kentucky’s opioid commission, managing $842 million in settlements from opioid manufacturers.

4:12 - Limitations of Current Treatments
The discussion critiques existing opioid treatments (e.g., Suboxone, methadone) with a 25% success rate, highlighting the need for better solutions.

5:05 - Discovery of Ibogaine’s Potential
Bryan shares how he learned about Ibogaine’s impact on addiction through Compass Pathways’ psilocybin research and Juliana Christina’s writings.

7:16 - Introduction to Ibogaine
Angela introduces Ibogaine, derived from the Iboga plant used by the Bwiti tribe, and its cultural significance as “eating God.”

8:04 - Kentucky’s Ibogaine Proposal and Setback
Bryan recounts Kentucky’s plan to allocate $42 million for Ibogaine research, derailed by a new attorney general in 2023.

9:52 - Texas as the New Opportunity
The focus shifts to Texas’s potential to lead Ibogaine development, with legislation nearing approval as of May 13, 2025.

12:06 - Angela’s Personal Story with Addiction
Angela shares her history of generational alcoholism and her recovery through Ibogaine, emphasizing its non-addictive nature.

16:46 - Angela’s Experience with Chronic Lyme Disease
Angela describes using Ibogaine to treat chronic Lyme disease, detailing her physical and emotional struggles.

19:49 - Ibogaine’s Role in Healing
Angela explains how Ibogaine helped her sleep, heal her brain, and overcome addiction, highlighting its profound effects.

27:54 - Casey Skudin 343 Fund and First Responders
Angela introduces the Casey Skudin 343 Fund, created after her husband’s death, to provide Ibogaine treatment for first responders.

32:58 - How Ibogaine Works in the Brain
Bryan discusses Ibogaine’s mysterious mechanism, citing expert opinions on its divine design and neurological restoration.

38:05 - Ibogaine’s Efficacy Data
Bryan shares that 80% of patients resolve substance dependency within 36-48 hours, with 97% success after a second dose.

44:09 - Bryan’s Personal Ibogaine Experience
Bryan and his wife’s Ibogaine journey at Ambio Clinic is detailed, addressing anxiety and postpartum depression.

51:38 - Ibogaine for Traumatic Brain Injuries (TBI)
The conversation explores Ibogaine’s potential for TBI, referencing a Parkinson’s patient’s recovery and a severe TBI case.

1:13:28 - Call to Action and Cultural Change
Bryan and Angela urge viewers to share the video, contact elected officials, and support the 343 Fund to advance the Ibogaine initiative.